ENVERIC BIOSCIENCES, INC. Shareholders' Equity
ENVERIC BIOSCIENCES, INC. (ENVB) had Shareholders' Equity of $8.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.08M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $5.06M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $4.18M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.46M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $8.08M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $5.06M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $4.18M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.46M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.18M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $3.92M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $1.59M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $3.95M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $5.41M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $6.48M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $1.96M 10-K · filed 2026-03-27 | |
| 2023-09-30 | $2.44M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $4.87M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $10.41M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $14.67M 10-K · filed 2025-03-28 | |
| 2022-09-30 | $22.84M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $21.97M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $24.44M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $22.31M 10-K · filed 2024-03-26 | |
| 2021-09-30 | $55.37M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $18.82M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $18.99M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $3.42M 10-K/A · filed 2023-06-09 | |
| 2020-09-30 | -$3.59M 10-Q · filed 2021-11-15 | $13.18M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$3.48M 10-Q · filed 2021-11-15 | $12.88M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$2.70M 10-Q · filed 2021-11-15 | $10.22M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$1.81M 10-K · filed 2022-03-31 | $10.62M 10-K · filed 2020-03-25 |
| 2019-09-30 | $13.25M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $10.86M 10-Q · filed 2020-08-14 | $10.86M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $11.16M 10-Q · filed 2020-05-15 | |
| 2018-12-31 | -$65.45K 10-K · filed 2021-04-01 | $10.76M 10-Q · filed 2019-05-14 |
| 2018-09-30 | $30.09M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $18.30M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $19.18M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $19.45M 10-K/A · filed 2020-08-12 | $19.45M 10-Q · filed 2019-05-14 |
| 2017-09-30 | $12.22M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $13.62M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $14.77M 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | $11.66M 10-Q · filed 2017-11-13 | |
| 2016-09-30 | $4.75M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.41M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$800.06K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $258.53K 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $958.80K 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $1.12M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $972.86K 10-K/A · filed 2017-04-04 | -$6.45K 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$3.87K 10-Q · filed 2015-05-14 | |
| 2014-09-30 | $6.83K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $10.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $424.56K 10-KT · filed 2016-03-15 | $21.91K 10-Q/A · filed 2014-05-08 |
| 2013-12-31 | -$20.23K 10-K · filed 2015-03-31 | |
| 2013-09-30 | -$33.21K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$28.66K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$24.76K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | -$20.07K 10-K · filed 2015-03-31 | |
| 2012-09-30 | -$8.44K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$3.57K 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $510.00 10-Q/A · filed 2012-05-10 | |
| 2011-12-31 | $4.55K 10-K · filed 2014-03-28 | |
| 2011-09-30 | $16.68K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$64.23K 10-Q · filed 2011-08-02 | |
| 2010-12-31 | -$49.52K 10-K · filed 2013-02-28 | |
| 2009-12-31 | -$10.07K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |